OAR 431-121-2030: Preferred Drug List

(1) The Administrator shall consider any PDL developed and recommended by OHPR that identifies preferred choices of prescription drugs within therapeutic classes for particular diseases and conditions, including generic alternatives, for use in the OPDP by participating programs. (2) The OPDP shall develop a PDL that participating programs may choose to adopt for beneficiaries of their prescription drug benefit program. The PDL shall include the most effective prescription drugs at the lowest possible prices, taking into account negotiated price discounts and rebates available to the OPDP, while allocating and distributing the operational costs of the OPDP. (3) If a participating program uses the PDL developed by the OPDP, it must be used in conjunction with that participating program’s benefit plan including all pharmacy management programs the participating program has or adopts. (4) OPDP shall make the PDL available to individuals enrolled in the OPDP.